Jay Parrish
InvestorVenture Partner at ARCH Venture Partners
United States
Writes $50K β $150M checks Β· typically $25M
Experience
- Pretzel TherapeuticsChairman and CEOcurrent2021 β presentBoston, Massachusetts, United States
- ARCH Venture PartnersVenture Partnercurrent2016 β presentUnited States
- Amplitude TherapeuticsCo-Founder and Chairmancurrent2022 β presentBoston, Massachusetts, United States
- Magnet BiomedicineStrategic Advisor and Board Membercurrent2023 β presentBoston, Massachusetts, United States
- Gate BioscienceBoard Observercurrent2021 β presentSan Francisco Bay Area
- Vaccine CompanyStrategic Advisor2023 β 2026San Francisco Bay Area
- Lilac TherapeuticsChairman of the Board2020 β 2026Richmond, California, United States
- Interline TherapeuticsMember Board Of Directors2021 β 2026San Francisco Bay Area
- ROME TherapeuticsCo-Founder and Member Board Of Directors2019 β 2025Cambridge, Massachusetts, United States
- Orbital TherapeuticsStrategic Advisor2022 β 2025Cambridge, Massachusetts, United States
- HI-Bio: A Biogen CompanyStrategic Advisor2021 β 2024San Francisco Bay Area
- Vir Biotechnology, Inc.Co-Founder and Chief Business Officer2016 β 2021San Francisco Bay Area
- Guide TherapeuticsMember Board Of Directors2020 β 2021Atlanta, Georgia, United States
- University of California, BerkeleyInstructor2012 β 2020Belmont, CA
- Gilead SciencesCorporate Development2011 β 2016Foster City, CA
- Gilead SciencesScientist, Medicinal Chemistry2004 β 2011Foster City, CA
- Abide TherapeuticsStrategic Advisor2009 β 2011San Diego, California, United States
- The Scripps Research InstitutePostdoctoral Fellow2002 β 2004La Jolla, CA
Education
- University of California, Berkeley, Haas School of BusinessMBA, Finance2008 β 2011
- University of South FloridaPhD, Synthetic Organic Chemistry1996 β 2001
- Emory UniversityBS, Chemistry1993 β 1996
- Chamberlain Senior High School
Skills & more
Corporate Development22Business Development20Mergers6Due Diligence10Financial Modeling7Valuation4Venture Capital3Drug Development61Drug Discovery99Biotechnology75Oncology29Infectious Diseases24
+12 more
Synthetic Organic ChemistryOrganic SynthesisMergers & AcquisitionsMedicinal ChemistryVirologyChemistryFDAClinical TrialsHepatitis CHIVRSVPharmaceutical IndustryFrom Jay's professional profile.
Same school
Also attended University of California, Berkeley, Haas School of Business489
Mark FiorentinoInvestor at Index VenturesRishi ModiInvestor at GV (Google Ventures)Yibo NianInvestment Director at Intel CapitalZhenyu TangInvestment Director at Intel CapitalHariFellow at Clear VenturesDennisDirector of Trading at Pantera Capital
+ 483 more
Also attended University of South Florida20
MarkInvestor at Yu GalaxyOmar Al RamlawiResearch at Transform Capital ManagementElias TorresInvestor at Array Ventures Management LlcJonathan MercadoPrincipal at First Bight VenturesFrankie VinasSenior Portfolio Monitoring Analyst at HeadlineTara JordanInvestor Relations at Creci Ventures
+ 14 more
Also attended Emory University97
Dave MunichielloInvestor at GV (Google Ventures)Ryan HaysBoard Member at CincyTechJustin RobenyAssociate at Osage University PartnersZitong SuAssociate at Marlin Equity PartnersGurbani SinghPrincipal - Investor Relations at Marlin Equity PartnersCole LundquistPrincipal at QED Investors
+ 91 more
Shared employers
Also worked at ARCH Venture Partners25
Steve GillisManaging Director at ARCH Venture PartnersCarol SuhPartner at ARCH Venture PartnersSean KendallPartner (Europe) at ARCH Venture PartnersCorey RitterPartner at ARCH Venture PartnersLuciana BorioVenture Partner at ARCH Venture PartnersJoseph JeongVenture Partner at ARCH Venture Partners
+ 19 more
Also worked at Vir Biotechnology, Inc.3
Also worked at University of California, Berkeley142
Paul JennyBoard Chair at CincyTechAndrea van ElsasInvestor at Third Rock VenturesFreada Kapor KleinFounding Partner at Kapor CapitalUlili OnovakpuriManaging Partner at Kapor CapitalRoseanneCo-founder at Renegade PartnersElliot HershbergScientist, Writer, and Investor on a mission to accelerate The Century of Biology
+ 136 more
Colleagues at ARCH Venture Partners
Ari Nowacek
Partner at ARCH Venture Partners
Axel Bouchon
Venture Partner at ARCH Venture Partners
Brian Cuneo
Senior Partner at ARCH Venture Partners
Carol Suh
Partner at ARCH Venture Partners
Clinton Bybee
Co-founder & Managing Director, Emeritus at ARCH Venture Partners
Corey Ritter
Partner at ARCH Venture Partners
David Moore
Senior Partner at ARCH Venture Partners
George Scangos
Venture Partner at ARCH Venture Partners


































.png)





